Abstract
INTRODUCTION:Venous sinus thrombosis is considered one of the most infrequent causes of cerebrovascular disease (CVD), prevalent in young people. It usually has an insidious onset which difficult its diagnosis and timely initiation of treatment and is associated with multiple risk factors including hypercoagulable states, as in those patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infection.
CASE REPORT:The following are 2 clinical cases of patients with neurological alterations, diplopia, and status epilepticus, in whom extensive venous thrombosis of infrequent location was documented through symptomatology and imaging studies, ruling out the main associated etiologies, with the only associated nexus: SARS-CoV-2 infection. Both patients received treatment with parenteral anticoagulation, responding successfully and were subsequently discharged with oral anticoagulation.
DISCUSSION:It is essential to be aware of this disease associated with a high diagnostic suspicion given its varied clinical manifestations and its increasingly frequent association with COVID-19 infection.
References
Dmytriw AA, Song JSA, Yu E, Poon CS. Cerebral venous thrombosis: state of the art diagnosis and management. Neuroradiology. 2018;60(7):669-85. doi: 10.1007/s00234-018-2032-2.
Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-21. http://dx.doi.org/10.1177/239698731771936
Ferro JM, Aguiar de Sousa D. Cerebral venous thrombosis: An update. Curr Neurol Neurosci Rep. 2019;19(10):74. http://dx.doi.org/10.1007/s11910-019-0988-x
Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-92. http://dx.doi.org/10.1161/STR.0b013e31820a8364
Zuurbier SM, Coutinho JM. Cerebral venous thrombosis. Adv Exp Med Biol. 2017;906:183-93. http://dx.doi.org/10.1007/5584_2016_115
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. http://dx.doi.org/10.1056/NEJMoa2002032
Vergara JP, Tolosa C. Covid 19: manifestaciones neurológicas. Acta Neurol Colomb. 2020;36(2 Supl. 1):7-10. http://dx.doi.org/10.22379/24224022288
Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41(12):3437-70. http://dx.doi.org/10.1007/s10072-020-04801-y
Mahammedi A, Saba L, Vagal A, Leali M, Rossi A, Gaskill M, et al. Imaging of neurologic disease in hospitalized patients with COVID-19: An Italian multicenter retrospective observational study. Radiology. 2020;297(2):E270-3. http://dx.doi.org/10.1148/radiol.2020201933
Baldini T, Asioli GM, Romoli M, Carvalho Dias M, Schulte EC, Hauer L, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3478-90. http://dx.doi.org/10.1111/ene.14727
Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-20. http://dx.doi.org/10.1515/cclm-2020-0188
Saavedra Trujillo CH. Sección VIII. Prevención y control de la infección por SARS-CoV-2/COVID-19. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud: Recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS. Segunda edición. 1.o de agosto de 2020. Infectio. 2020;24(3). http://dx.doi.org/10.22354/in.v24i3.872
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. http://dx.doi.org/10.1182/blood.2020006000
Atallah B, Mallah SI, AlMahmeed W Anticoagulation in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):260-1. http://dx.doi.org/10.1093/ehjcvp/pvaa036
Acevedo-Peña J, Yomayusa-González N, Cantor-Cruz F, Pinzón-Flórez C, Barrero-Garzón L, De-La-Hoz-Siegler I, et al. Consenso colombiano para la prevención, el diagnóstico y el tratamiento de condiciones trombóticas en adultos con COVID-19: aplicando el Marco de la Evidencia a la Decisión (EtD) GRADE. Rev Colomb Cardiol. 2020;27(5):446-60. http://dx.doi.org/10.1016/j.rccar.2020.08.003

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
